Subscribe to our social channels to get the latest news about Hungary!
Hungarian research breakthrough could increase survival time of lung cancer patients
Change language:
Application of deuterium depletion in combination with other conventional therapies inhibits lung cancer cell growth and migration; thus, it can help increase the survival time of non-small cell lung cancer patients.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer: about 84% of lung cancers are NSCLC. In advanced NSCLC, the median survival time is approximately 10-12 months. Hungary is a world leader in lung cancer deaths, with about 10,000–11,000 new lung cancer cases every year, writes Infostart. In a recent study published in the Journal of Cancer Research & Therapy, Hungarian scientists at HYD LLC. for Cancer Research and Drug Development, the University of Szeged and Avidin Ltd. revealed that a submolecular approach to tumour cell physiology could be the key to more effective cancer treatment. They analysed the effects of deuterium depletion on cancer cells, focusing on the median survival time of NSCLC patients.
The retrospective study involved 183 patients receiving conventional cancer treatment whose daily amount of fluid intake was replaced with deuterium-depleted water for at least 91 days. The experiments revealed that naturally occurring deuterium plays an important role in cell growth and deuterium depletion causes tumour regression.
Magyarorszag needs a comprehensive anti-smoking program that highlights the ravages of lung disease, alongside an emphasis on physical education and sports at all grade levels. Health habits formed at an early age follow into adulthood. Healthy, active adults don’t want to smoke.